ClinicalTrials.gg
RecruitingNCT07506460Updated Apr 1, 2026

Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk: Aim 2b

An interventional study of Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and Youth-Nominated Support Team in Suicide Prevention, Suicide and Self-Injurious Behavior, sponsored by University of Michigan. Recruiting at 2 sites in United States. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2026-04-01.

Sponsored by University of Michigan · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started Mar 2026; still recruiting 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Not applicable
Ages
12 Years and older
Sex
All
01

Study summary

This is a second pilot study being completed based on lessons learned from the Aim 2a feasibility pilot study (NCT06941311). Following modifications, the investigators are testing the acceptability, feasibility, and preliminary effectiveness of the combination of two psychosocial interventions, Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and the computer-assisted version of the Youth-Nominated Support Team (eYST).

In this phase of the study, CBT-SP + eYST will be tested in an open trial (number of youth = 15). Investigators will recruit Black adolescents (ages 12-17) that come to an urban acute care setting for suicidal thoughts and/or self-injurious behaviors to receive the intervention in an outpatient community mental health agency. Participants will receive 12-14 sessions of CBT-SP in addition to YST. Participants will nominate up to 5 caring adults in their lives to serve as support persons. These support persons will attend an education/orientation session to learn more about their role and how to support the youth. Support persons will have weekly contact with the youth and weekly follow up contacts from the youth's clinician/YST intervention specialist.

Youth will be assessed at baseline, 6 weeks, and 14 weeks. Parents will be assessed at baseline and 14 weeks. Support persons will be assessed at baseline and 14 weeks.

Fidelity assessments will be completed by clinicians after each session, after the YST psycho-ed session, and weekly to document contact with the support team.

02

Conditions studied

  • Suicide Prevention
  • Suicide
  • Self-Injurious Behavior
  • Behavioral Symptoms
  • Behavior

Keywords

  • Black youth
  • Acute suicide risk
  • Youth Nominated Support Team
  • Cognitive Behavioral therapy for Suicide Prevention
  • Community Mental Health
  • Suicide prevention
  • Behavior Therapy
  • Psychotherapy
  • Behavioral Disciplines and Activities
  • Cognitive Behavioral Therapy
03

In context

Suicide Prevention

186 studies on the registry are indexed under Suicide Prevention; 92 are open to participants now.

This study's planned enrollment of 90 is below the median of 140 across 167 interventional studies indexed under Suicide Prevention.

Browse Suicide Prevention studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,506 studies on the registry; 192 are open to participants now.

Of its 169 completed or terminated interventional studies of FDA-regulated products, 133 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Youth Inclusion Criteria:

  • Patients that are able to provide at least one verifiable contact for emergency or tracking purposes
  • Willing to receive care at MiSide
  • Present to an acute emergency care setting with suicide risk (per protocol)
  • Self-identify as Black
  • Willing and able to complete enrollment procedures
  • Willing and able to provide signed and dated informed assent

Youth Exclusion Criteria:

  • Unable to be consented in English
  • Do not have a parent/legal guardian available to provide consent
  • Are not able to provide informed assent or to participate in the assessment due to significant agitation, psychosis, cognitive impairment, learning disability, or medical trauma
  • Actively engaged in specialty mental health treatment
  • Participated in the Aim 2a open trial

Parent/Guardian Inclusion Criteria:

  • Adults 18 years and older
  • The parent or legal guardian of a youth participating in this Aim
  • Understand written and spoken English
  • Willing and able to complete enrollment procedures
  • Willing and able to provide signed and dated
  • Need to have access to technology, either cell or an email address

Parent/Guardian Exclusion Criteria:

- Do not understand written and spoken English

Support Person Inclusion Criteria:

  • Adults 18 years and older
  • Understand written and spoken English
  • Approved to serve as a support person by the parent/legal guardian

Support Person Exclusion Criteria:

  • Do not understand written and spoken English
  • Not approved to serve as a support person by the parent/guardian
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    CBT for Suicide Prevention plus the Youth-Nominated Support Team

    Participation will be 3 months.

    Behavioral: Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) · Behavioral: Youth-Nominated Support Team

Interventions

  • BehavioralCognitive Behavioral Therapy for Suicide Prevention (CBT-SP)

    Clinicians will provide this specialized evidence based mental health care. The study focuses on the acute phase of CBT-SP, which is 12 sessions. CBT-SP's goals are to reduce suicide risk factors, enhance coping, and prevent future suicidal behavior. Identifying the emotional, cognitive, behavioral, or familial processes that precede a suicide crisis is a major focus, which yields an individualized treatment plan. Each session lasts one hour and can be completed either in person or via a secure telehealth platform. Most youths will attend sessions on a weekly basis and therapists will prioritize parent engagement

  • BehavioralYouth-Nominated Support Team

    Youth will nominate up to 5 trusted adults. Following parental approval, Support Persons will attend a psychoeducational orientation session with their assigned intervention specialist (i.e., the youth's clinician), learn about the youth's difficulties, treatment plan, and receive ideas for supporting the youth. Support Persons will be asked to have contact with the youth each week for the 3 months of the study. During these calls, Support Persons have an opportunity to discuss any questions or concerns they may have about the youth and how best to support them.

06

What researchers measure

Primary outcomes

  1. Acceptability - percent of eligible youth consented

    The intervention will be considered acceptable if at least 50% of eligible youth approached for participation choose to enroll in the study.

    Time frame: Baseline

  2. Feasibility - Mean number of support people

    The intervention will be considered feasible if the mean number of support people per youth is at least 3.

    Time frame: 6 weeks

  3. Acceptability - Mean number of support person contacts

    The intervention will be considered acceptable if the mean number of support person contacts with youth is at least 7.

    Time frame: 14 weeks

  4. Feasibility - Number of CBT-SP sessions attended

    Number of CBT-SP sessions attended by youth

    Time frame: 14 weeks

07

Study locations

2 of 2 sites recruiting
  • Children's Hospital of Michigan (CHM) Emergency Department
    Detroit, Michigan 48201, United States
    Recruiting
    • Christina Magness, LMSW · Contactcmagness@med.umich.edu · 734-252-6315
    • Curt Stankovic, MD · Principal investigator
  • MiSide
    Detroit, Michigan 48210, United States
    Recruiting
    • Christina Magness, LMSW · Contactcmagness@med.umich.edu · 734-252-6315
    • Marquita Felder, LMSW · Principal investigator
08

References and documents

Individual participant data

Plan to share: Yes — Upload to National Institute of Mental Health (NIMH) Data Archive.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: After the study is completed and available according to NIMH Data Archive policy.

Access criteria: Researchers can request de-identified data from the study contacts listed in the study.

Data sharing details ↗ · nda.nih.gov

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Aug 2026, 5 months after the start.

Of 127 non-industry interventional studies with no phase under Suicide Prevention, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 53. This study's planned 5 months is below that.

Counting every sponsor, half of 129 studies reached it within 28 months; a quarter within 12 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 26, 2026
First posted
Apr 1, 2026
StartActual
Mar 23, 2026
Primary completionEst.
Aug 2026
CompletionEst.
Aug 2026
Last update
Apr 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07506460
Collaborators
National Institute of Mental Health (NIMH), MiSide, Children's Hospital of Michigan
Responsible party
Cynthia Ewell Foster (Clinical Professor, University of Michigan) — Principal investigator
First posted
Apr 1, 2026
Start date
Mar 23, 2026
Primary completion
Aug 2026 (estimated)
Completion
Aug 2026 (estimated)
Last update
Apr 1, 2026

Study contacts

Christina Magness, LMSW
Contact
cmagness@med.umich.edu
734-252-6315
Cynthia Ewell Foster, PhD
principal investigator · University of Michigan

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion